News
Regeneron buying 23andMe
Digest more
Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 ...
In the latest episode of Touching Base, we discuss big news in CRISPR along with updates in the business side of biotech.
The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.
Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million: Tarrytown, New York Wednesday, May 21, 2025, 13:00 Hrs [IST] Regeneron Pharmace ...
Regeneron Pharmaceuticals ... A pharmacist in a lab coat carefully analyzing a vial of medicine for its quality. The deal is subject to bankruptcy court and regulatory approvals and other ...
Regeneron earns a buy rating with strong profit margins, low debt, and growth potential. Discover why shares may see a 39% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results